Genetic Diseases in Active Gene Editing Clinical Trials and Progress (As of May 2025, based on global clinical trial data) I. Hematologic Disorders 1. Sickle Cell Disease (SCD) & β-Thalassemia Candidate Therapies: exa-cel (CTX001): Co-developed by CRISPR Therapeutics and Vertex, this therapy act…
Latest Applications of Gene Editing in Genetic Disease Treatment (As of May 2025) Gene editing technologies are revolutionizing the treatment of genetic disorders. Below is a systematic review of recent advancements across four dimensions: technical breakthroughs, clinical applications, multi-system…
Selecting the Optimal Treatment for Coronary Artery Disease and the Importance of Daily Health Management (As of May 2025) I. Strategies for Choosing CAD Treatments Effective management of coronary artery disease (CAD) requires a personalized approach that integrates disease severity, patient-specif…
Traditional Treatments and Best Practices for Coronary Artery Disease (CAD) (As of May 2025) The traditional treatment system for coronary artery disease (CAD) encompasses pharmacological therapies, surgical interventions, minimally invasive procedures, cardiac rehabilitation, and traditional Chines…
Gene Editing Technologies for Coronary Artery Disease (CAD) Treatment (As of May 2025) The treatment of coronary artery disease (CAD) has entered an era of precision intervention through gene editing. Below is a systematic review of current gene-editing technologies applied to CAD, covering mechanis…
Innovative Strategies Combining Surgical and Gene-Editing Therapies for Coronary Heart Disease (As of May 2025) The treatment of coronary artery disease (CAD) has evolved from traditional surgical interventions to a precision medicine era. Recent advances in combining gene-editing technologies with …
Potential Risks of Gene Editing in Coronary Heart Disease (As of May 2025) Gene editing technologies (e.g., CRISPR-Cas9, base editing) offer revolutionary strategies for treating coronary heart disease (CHD), but their clinical application faces multidimensional risks. Below is an analysis spanning …
Comparative Analysis of Immunotherapy vs. Gene Editing Therapy (As of May 2025) 1. Core Mechanisms and Targets Immunotherapy Principle: Activates or enhances the patient’s immune system to recognize and kill tumor cells, primarily through engineered T cells (e.g., CAR-T) or immune checkpoint inhibit…
Latest Advances in Gene Technology for Common Disease Treatment (As of May 2025) Breakthroughs in CRISPR-Cas9, base editing, and mRNA delivery have propelled gene technology from labs to clinics, revolutionizing treatments for cancer, cardiovascular diseases, genetic disorders, and more. Below are k…
Coronary Heart Disease as a Paradigm of Gene-Environment Interaction: Genetic Mechanisms, Environmental Regulation, and Clinical Translation Coronary heart disease (CHD) arises from a dynamic interplay between genetic and environmental factors. Modern genomics and epidemiological studies confirm tha…